EBMT

At #EBMT26, @Mohty_EBMT shared insight into the sequencing of bispecifics and #CARTCell therapy in patients with #MultipleMyeloma.🩸 To find out more, click here: 🎥 ow.ly/bNqZ50YVFxQ #MMSM #Myeloma #ImmunoOnc #HemOnc @TheEBMT

🆕 JACIE has completed its first inspection under the 3rd IEC Standards at Guy’s and St Thomas’ NHS Foundation Trust. @GSTTnhs 🏥 ➡️ This milestone launches a certification pathway for IEC therapy programmes beyond transplant settings. 🔎 Read more: ebmt.org/ebmt/news/jaci…

⏰ Last chance: enjoy the on-demand content from #EBMT26 before the Virtual Platform closes on ⌛ Sunday, 10 May at 23:59 CEST. 💻 ✍️ Revisit your favourite sessions and latest research findings presented during the congress: ebmt.org/annual-meeting… #HCT #CellTherapy #GeneTherapy #hematology

The biggest breakthroughs from @TheEBMT are here. The EBMT Congress Supplement brings together the most impactful research, expert interviews, and award-winning insights shaping hematology and transplantation. From practice-changing data to expert perspectives, discover what mattered most at this year’s congress. Access it now via the link: hubs.la/Q04fZl7l0

@josudelafuente @DrSunilBhat @nadahamad @thalassaemiaTIF

📰 Today on #ITD2026, the Haemoglobinopathies Working Party of EBMT highlights the urgent need for earlier diagnosis, equitable access to care and better recognition of every individual living with #thalassaemia. 👉 Discover more in the recent article by Emanuele Angelucci and Josu de la Fuente: ebmt.org/ebmt/news/driv… #hematology #hemoglobinopathies #CellTherapy #GeneTherapy #HiddenNoMore #VisibilityVoiceValue

@DrSunilBhat @nadahamad @thalassaemiaTIF

Watch the full episode 🎬 with @DrSunilBhat and @nadahamad on YouTube 🎥 youtu.be/5PsXBMq0ydU?is…

Today marks International Thalassaemia Day 📅 From local awareness efforts to national campaigns and educational initiatives, every action contributes to a shared global effort to raise awareness and drive change. 🌏 This year's #ITD2026 campaign shines a light on people living without diagnosis, support, or recognition. No person living with #thalassaemia should remain unseen. #HiddenNoMore #VisibilityVoiceValue

On #WorldThalassemiaDay, @DrSunilBhat, Director and Head of Department, Pediatric Hematology, Oncology and Bone Marrow Transplant, @cancercent31046, @NarayanaHealth Bangalore, shares his thoughts on thalassemia awareness and patient care. @coalindia @ministryofcoal @mohfwindia @delhigov @tif_thalassaemia @shobhatuli #ThalassemiaAwareness #ThalassemiaCare #EarlyDiagnosis #BoneMarrowTransplant #PediatricHematology #PatientCare #HealthcareAwareness

📰 Today on #ITD2026, the Haemoglobinopathies Working Party of EBMT highlights the urgent need for earlier diagnosis, equitable access to care and better recognition of every individual living with #thalassaemia. 👉 Discover more in the recent article by Emanuele Angelucci and Josu de la Fuente: ebmt.org/ebmt/news/driv… #hematology #hemoglobinopathies #CellTherapy #GeneTherapy #HiddenNoMore #VisibilityVoiceValue

@TheEBMT @MET2026 @i_yakoub_agha is giving a openning lecture on innovation in SCT fifty year history

In a recent interview at #EBMT26, we spoke with @MSubklewe (@LMU_Muenchen) to gain insights into the GoCART Observership Programme. 🎥 Click here to watch: 👉 ow.ly/A5LE50YVEHP 👈 #CART #CARTCell #ImmunoOnc #HemOnc @GoCARTcoalition @TheEBMT

📝 During the GvHD Hub live symposium at #EBMT26, Hildegard Greinix shared her clinical experience in treating #GvHD with ECP. Watch the full video here: bit.ly/42ij2ax Intended for healthcare professionals only. Independently supported by Therakos. Funders are allowed no influence. #GvHDsm #MedEd @TheEBMT

We recently spoke with Matteo Della Porta (@HumanitasMilano) to gain insights into the potential of AI-driven synthetic data generation in #Hematology. 🩸 Click here to watch the full interview: 🎥 ow.ly/7a1750YRF3T #BMTsm #HemOnc #EBMT26

It was a pleasure to be a speaker in the EBMT Hemoglobinopathies Working Party Webinar on SCD, recording of the talk: ebmt.org/haemoglobinopa… @TheEBMT #Hematology #MedTwitter

Huge thanks to @DrLornan for his supervision and co-leadership, to Gabriel Naylor Layland and Amy Kirkwood for the analytical heavy lifting, and to all 16 UK centres who contributed data. Another success of our collaborative MPN research network in the UK. 🙏 Full paper (open access): doi.org/10.1111/bjh.70…

What are some of the common misconceptions about #CARTCell therapy in #DLBCL that physicians may have? @AnnaSureda5 (@ICO_oncologia) shared insight into this in a recent interview: ➡️ ow.ly/HiNr50YRIES #Lymphoma #LYMsm #ImmunoOnc #HemOnc #EBMT26 @TheEBMT

👉 New paper from @TheEBMT practice harmonisation and guidelines committee: practical approaches to defining remission and relapse after allo-HCT in MDS/MPN overlap syndromes — a pragmatic approach to these challenging 🩸 disorders! @TheEBMT_Trainee @CArmstrongHaem #MDSsm #MPNsm gbr01.safelinks.protection.outlook.com/?url=https%3A%…

📣 Present your work at #ITCTC26 - submit your case before 18 May. 📅 This year’s programme includes: 🗣️ 12 oral presentation slots, and 📰 A dedicated poster flash talks session Discover more, apply for a Travel Grant and share your work ➡️ ebmt.org/events/11th-in… #HCT #transplantation #CellTherapy #EducationalMeeting